Once-a-day Alzheimer’s pill reaches US approval milestone
MELBOURNE: A once-a-day “holy grail” pill that could change the way Alzheimer’s disease is treated
MELBOURNE: A once-a-day “holy grail” pill that could change the way Alzheimer’s disease is treated